Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Angela M. Cocoman & Darren Gallagher. (2019) A Retrospective Chart Review of Screening on the Prevalence of Metabolic Syndrome (MetS) in an Irish Community Mental Health Service. Issues in Mental Health Nursing 40:10, pages 895-901.
Read now
Read now
Y Asahi, Y Kawai, M Sugimoto, T Suzuki, S Omichi & J Kotani. (2009) Anaesthesia for a morbidly obese patient with schizophrenia and intellectual disability. Southern African Journal of Anaesthesia and Analgesia 15:5, pages 32-33.
Read now
Read now
Joshua T Kantrowitz & Leslie Citrome. (2008) Olanzapine: review of safety 2008. Expert Opinion on Drug Safety 7:6, pages 761-769.
Read now
Read now
. (2008) Supplement Issue. Annals of Clinical Psychiatry 20:sup1, pages 1-32.
Read now
Read now
Articles from other publishers (38)
Houda El Kirat, Asmaa Khattabi, Mohamed Khalis & Zakaria Belrhiti. (2023) Effects of physical activity and nutrient supplementation on symptoms and well-being of schizophrenia patients: An umbrella review. Schizophrenia Research 262, pages 112-120.
Crossref
Crossref
Marco Carli, Shivakumar Kolachalam, Biancamaria Longoni, Anna Pintaudi, Marco Baldini, Stefano Aringhieri, Irene Fasciani, Paolo Annibale, Roberto Maggio & Marco Scarselli. (2021) Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences. Pharmaceuticals 14:3, pages 238.
Crossref
Crossref
Shohinee Sarma, Sanjeev Sockalingam & Satya Dash. (2021)
Obesity as a
multisystem
disease: Trends in obesity rates and
obesity‐related
complications
. Diabetes, Obesity and Metabolism 23:S1, pages 3-16.
Crossref
Crossref
Mohammad Marie, Zareefa Shaabna & Manahel Saleh. (2020) Schizophrenia in the context of mental health services in Palestine: a literature review. International Journal of Mental Health Systems 14:1.
Crossref
Crossref
Laís Bhering Martins, Silvia Fernandes Mauricio, Adaliene Versiani Matos Ferreira & Antônio Lúcio Teixeira. 2020. Obesity and Diabetes. Obesity and Diabetes
415
426
.
Halise Devrimci-Ozguven, Murad Atmaca, Zeynep Baran, Cengiz Cengisiz, Cem Çinar, Atila Erol, Yasin Genç, Hasan Karadağ, Kamuran Karakülah, Umut Karasu, Mehmet Cemal Kaya, Emre Kizil, Halil Özcan, Ahmet Tiryaki, Alp Üçok, Cenk Varlik, Sila Menekşe Yazar & Mesut Yildiz. (2019) Efficacy and Safety of Paliperidone Palmitate Treatment in Patients With Schizophrenia. Journal of Clinical Psychopharmacology 39:6, pages 604-610.
Crossref
Crossref
Ching-En Lin, Chi-Hsiang Chung, Li-Fen Chen & Wu-Chien Chien. (2019) Increased risk for venous thromboembolism among patients with concurrent depressive, bipolar, and schizophrenic disorders. General Hospital Psychiatry 61, pages 34-40.
Crossref
Crossref
Laís Bhering Martins, Nayara Mussi Monteze, Chadi Calarge, Adaliene Versiani Matos Ferreira & Antônio Lúcio Teixeira. (2019) Pathways linking obesity to neuropsychiatric disorders. Nutrition 66, pages 16-21.
Crossref
Crossref
Frederik VandenbergheAlexandra Najar-GiroudLaurent HolzerPhilippe ConusChin B. EapAnne-Emmanuelle Ambresin. (2018) Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain. Journal of Child and Adolescent Psychopharmacology 28:4, pages 258-265.
Crossref
Crossref
Alessandro Rimessi, Chiara Pavan, Elli Ioannidi, Federica Nigro, Claudia Morganti, Alberto Brugnoli, Francesco Longo, Chiara Gardin, Letizia Ferroni, Michele Morari, Vincenzo Vindigni, Barbara Zavan & Paolo Pinton. (2017) Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain. Neuropsychopharmacology 42:7, pages 1491-1501.
Crossref
Crossref
Fernando Pires Hartwig, Jack Bowden, Christian Loret de Mola, Luciana Tovo-Rodrigues, George Davey Smith & Bernardo Lessa Horta. (2016) Body mass index and psychiatric disorders: a Mendelian randomization study. Scientific Reports 6:1.
Crossref
Crossref
W. Zheng, Y.‐T. Xiang, Y.‐Q. Xiang, X.‐B. Li, G. S. Ungvari, H. F. K. Chiu & C. U. Correll. (2016) Efficacy and safety of adjunctive topiramate for schizophrenia: a meta‐analysis of randomized controlled trials. Acta Psychiatrica Scandinavica 134:5, pages 385-398.
Crossref
Crossref
Chung-Chih Hsu, Chih-Sung Liang, Yueh-Ming Tai & Shu-Li Cheng. (2016) Incongruent changes in heart rate variability and body weight after discontinuing aerobic exercise in patients with schizophrenia. International Journal of Psychophysiology 109, pages 132-137.
Crossref
Crossref
Fang Wang, Weifeng Mi, Wenbin Ma, Cuicui Ma, Yongfeng Yang, Hongxing Zhang, Bo Du, Keqing Li, Chenxing Liu, Lifang Wang, Tianlan Lu, Hongyan Zhang, Luxian Lv, Dai Zhang & Weihua Yue. (2015)
A pharmacogenomic study revealed an association between
SLC6A4
and risperidone-induced weight gain in Chinese Han population
. Pharmacogenomics 16:17, pages 1943-1949.
Crossref
Crossref
Z. Whitney, R. M. Procyshyn, D. H. Fredrikson & A. M. Barr. (2015) Treatment of clozapine-associated weight gain: a systematic review. European Journal of Clinical Pharmacology 71:4, pages 389-401.
Crossref
Crossref
A. Ventriglio, A. Gentile, R.J. Baldessarini, S. Martone, G. Vitrani, A. La Marca & A. Bellomo. (2020) Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients. European Psychiatry 29:7, pages 402-407.
Crossref
Crossref
Amy M. Kilbourne, Margretta Bramlet, Michelle M. Barbaresso, Kristina M. Nord, David E. Goodrich, Zongshan Lai, Edward P. Post, Daniel Almirall, Lilia Verchinina, Sonia A. Duffy & Mark S. Bauer. (2014) SMI Life Goals: Description of a randomized trial of a Collaborative Care Model to improve outcomes for persons with serious mental illness. Contemporary Clinical Trials 39:1, pages 74-85.
Crossref
Crossref
Martha Sajatovic, Brent P Forester, Ariel Gildengers & Benoit H Mulsant. (2013) Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care. Neuropsychiatry 3:6, pages 621-633.
Crossref
Crossref
Michael Berk, Lana J Williams, Felice N Jacka, Adrienne O’Neil, Julie A Pasco, Steven Moylan, Nicholas B Allen, Amanda L Stuart, Amie C Hayley, Michelle L Byrne & Michael Maes. (2013) So depression is an inflammatory disease, but where does the inflammation come from?. BMC Medicine 11:1.
Crossref
Crossref
José María Martínez-Ortega, Silvia Funes-Godoy, Francisco Díaz-Atienza, Luis Gutiérrez-Rojas, Lucía Pérez-Costillas & Manuel Gurpegui. (2013) Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review. European Child & Adolescent Psychiatry 22:8, pages 457-479.
Crossref
Crossref
Losiana NayakHarinandan TungaRajat K. De. (2013) Disease Co-Morbidity and the Human Wnt Signaling Pathway: A Network-Wise Study. OMICS: A Journal of Integrative Biology 17:6, pages 318-337.
Crossref
Crossref
Leslie CitromeLeslie Citrome. 2013. Handbook of Treatment-resistant Schizophrenia. Handbook of Treatment-resistant Schizophrenia
37
56
.
Yongfeng Yang, Wenqiang Li, Jingyuan Zhao, Hongxing Zhang, Xueqin Song, Bo Xiao, Ge Yang, Chengdi Jiang, Dai Zhang, Weihua Yue & Luxian Lv. (2012) Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients. Behavioral and Brain Functions 8:1.
Crossref
Crossref
Brian E Leonard, Markus Schwarz & Aye Mu Myint. (2012) The metabolic syndrome in schizophrenia: is inflammation a contributing cause?. Journal of Psychopharmacology 26:5_suppl, pages 33-41.
Crossref
Crossref
I. KANE, H. LEE, S. SEREIKA & J. BRAR. (2011) Feasibility of pedometers for adults with schizophrenia: pilot study. Journal of Psychiatric and Mental Health Nursing 19:1, pages 8-14.
Crossref
Crossref
Claus Michael Gross & Ludger Tebartz van Elst. 2012. Principles of Metabolic Surgery. Principles of Metabolic Surgery
153
157
.
Leslie Citrome. (2011) Treatment-refractory schizophrenia: what is it and what has been done about it?. Neuropsychiatry 1:4, pages 325-347.
Crossref
Crossref
Leslie Citrome, Richard I.G. Holt, Daniel J. Walker & Vicki Poole Hoffmann. (2011) Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder. Clinical Drug Investigation 31:7, pages 455-482.
Crossref
Crossref
M. V. Seeman. (2011) Preventing breast cancer in women with schizophrenia. Acta Psychiatrica Scandinavica 123:2, pages 107-117.
Crossref
Crossref
MARC DE HERT, CHRISTOPH U. CORRELL, JULIO BOBES, MARCELO CETKOVICH-BAKMAS, DAN COHEN, ITSUO ASAI, JOHAN DETRAUX, SHIV GAUTAM, HANS-JURGEN MÖLLER, DAVID M. NDETEI, JOHN W. NEWCOMER, RICHARD UWAKWE & STEFAN LEUCHT. (2011) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10:1, pages 52-77.
Crossref
Crossref
Lawrence Maayan & Leslie Citrome. 2011. Global Perspectives on Childhood Obesity. Global Perspectives on Childhood Obesity
265
277
.
Jeffrey S. Gonzalez, Sabrina A. Esbitt, Havah E. Schneider, Patricia J. Osborne & Elyse G. Kupperman. 2011. Psychological Co-morbidities of Physical Illness. Psychological Co-morbidities of Physical Illness
73
121
.
C. IGLESIAS-GARCÍA, A. TOIMIL-IGLESIAS & M. J. ALONSO-VILLA. (2010) Pilot study of the efficacy of an educational programme to reduce weight, on overweight and obese patients with chronic stable schizophrenia. Journal of Psychiatric and Mental Health Nursing 17:9, pages 849-851.
Crossref
Crossref
Pornpoj Pramyothin & Lalita Khaodhiar. (2010) Metabolic syndrome with the atypical antipsychotics. Current Opinion in Endocrinology, Diabetes and Obesity 17:5, pages 460-466.
Crossref
Crossref
. (2010) NUTRITION ISSUES FOR THE MENTAL HEALTH PATIENT POPULATION. Nutrition & Dietetics 67:2, pages 124-127.
Crossref
Crossref
Mehrul Hasnain, W. Victor R. Vieweg & Sonja K. Fredrickson. (2010) Metformin for Atypical Antipsychotic-Induced Weight Gain and Glucose Metabolism Dysregulation. CNS Drugs 24:3, pages 193-206.
Crossref
Crossref
Lawrence A. Maayan & Julia Vakhrusheva. (2010) Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment. Human Psychopharmacology: Clinical and Experimental 25:2, pages 133-138.
Crossref
Crossref
Edgardo Carrizo, Virginia Fernández, Lisette Connell, Ignacio Sandia, Dexy Prieto, Johana Mogollón, Dennys Valbuena, Iliana Fernández, Enma Araujo de Baptista & Trino Baptista. (2009) Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study. Schizophrenia Research 113:1, pages 19-26.
Crossref
Crossref